Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-98 in Antiretroviral Therapy-Naive HIV-Infected Individuals
NCT07433387Phase 2Recruiting
- Sponsor
- Shanxi Kangbao Biological Products
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lipovirtide in human immunodeficiency virus infection (HIV), sponsored by Shanxi Kangbao Biological Products. Started Jan 2026; status: recruiting.
02
Drugs
lipovirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07433387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07433387.